These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 1238135)

  • 1. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA.
    Hefti F; Melamed E; Sahakian BJ; Wurtman RJ
    Pharmacol Biochem Behav; 1980 Feb; 12(2):185-8. PubMed ID: 7189592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of narcotic analgesics on the turning behaviour of rats with 6-hydroxydopamine-induced unilateral nigro-striatal lesions.
    Slater P; Blundell C; Crossman AR
    Neuropharmacology; 1980 Feb; 19(2):187-93. PubMed ID: 6102357
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway.
    Reavill C; Leigh N; Jenner P; Marsden CD
    Exp Brain Res; 1979 Oct; 37(2):309-16. PubMed ID: 315328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions.
    Tolbert LC; Thomas TN; Middaugh LD; Zemp JW
    Brain Res Bull; 1979; 4(1):43-8. PubMed ID: 572739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of dopaminergic agonists on motor function.
    Costall B; Naylor RJ
    Adv Neurol; 1975; 9():285-97. PubMed ID: 1170715
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Br J Pharmacol; 1975 Oct; 55(2):289P-290P. PubMed ID: 1238135
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.
    Fuxe K; Ungerstedt U
    Pharmacol Ther B; 1976; 2(1):41-7. PubMed ID: 817332
    [No Abstract]   [Full Text] [Related]  

  • 9. 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.
    Ungerstedt U
    Pharmacol Ther B; 1976; 2(1):37-40. PubMed ID: 772721
    [No Abstract]   [Full Text] [Related]  

  • 10. Sex differences in dopaminergic and cholinergic activity and function in the nigro-striatal system of the rat.
    Miller JC
    Psychoneuroendocrinology; 1983; 8(2):225-36. PubMed ID: 6353470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biology of motivation.
    Grossman SP
    Annu Rev Psychol; 1979; 30():209-42. PubMed ID: 375810
    [No Abstract]   [Full Text] [Related]  

  • 12. Monkeys with nigrostriatal lesions effects of monoaminergic drugs.
    Goldstein M; Anagnoste B; Battista AF; Ogawa M
    Pharmacol Ther B; 1976; 2(1):97-103. PubMed ID: 817335
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.